Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 14, 2016; 22(34): 7841-7850
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7841
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7841
Table 1 Design and patient characteristics of included clinical trials
Publication | Study design | Sample (n) | Age (yr) | Male gender | Adenocarcinoma | Distal esophagus | Tumour length (cm) |
Verschuur et al[16], 2006 | Prospective | 42 | 65 ± 14 | 60% | 76% | 21% | 7.8 ± 2.4 |
cohort | |||||||
Kim et al[13], 2009 | Prospective | 17 | 68 ± 8 | 94% | 33% | 39% | 6.1 ± 2.6 |
randomized | |||||||
Park et al[15], 2010 | Prospective | 32 | 67 ± 9 | 75% | N/A | 53% | N/A |
cohort | |||||||
Battersby et al[12], 2012 | Prospective | 55 | 72 | 67% | 56% | 93% | 11.7 ± 2.5 |
cohort | (stent length) | ||||||
Kim et al[14], 2012 | Prospective | 48 | 68 ± 11 | 81% | 33% | 37% | N/A |
cohort | |||||||
Mezes et al[11], 2014 | Retrospective | 56 | N/A | 61% | 38% | 55% | N/A |
cohort |
- Citation: Hussain Z, Diamantopoulos A, Krokidis M, Katsanos K. Double-layered covered stent for the treatment of malignant oesophageal obstructions: Systematic review and meta-analysis. World J Gastroenterol 2016; 22(34): 7841-7850
- URL: https://www.wjgnet.com/1007-9327/full/v22/i34/7841.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i34.7841